Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Intra-Nodal Autologous Dendritic Cell Vaccination for Newly Diagnosed GBM
NCT00323115Phase 2Completed
- Sponsor
- Dartmouth Health
- Start
- May 2006
- Primary completion
- Apr 2008
- Modality
- Prophylactic Vaccines, Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of autologous dendritic cell vaccine in glioblastoma multiforme (GBM), sponsored by Dartmouth Health. Started May 2006; status: completed.
02
Drugs
autologous dendritic cell vaccine
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00323115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323115.